125 related articles for article (PubMed ID: 35348475)
1. Leiomyoma With Massive Lymphoid Infiltration: 2 Cases With Lymphocytic Vasculopathy and Angiocentric Germinal Centers.
Wong J; Roy SF; Provencher D; Maietta A; Rahimi K
Int J Gynecol Pathol; 2023 Mar; 42(2):155-158. PubMed ID: 35348475
[TBL] [Abstract][Full Text] [Related]
2. Uterine Leiomyoma with Massive Lymphoid Infiltrate in a Patient with History of Assisted In-Vitro Fertilization.
Prete MD; Collamarini M; Collamarini C; Sesti F; Mauriello A; Palmieri G
Turk Patoloji Derg; 2020; 36(3):251-255. PubMed ID: 31960941
[TBL] [Abstract][Full Text] [Related]
3. Uterine leiomyoma with massive lymphoid infiltration: case report and review of the literature.
Paik SS; Oh YH; Jang KS; Han HX; Cho SH
Pathol Int; 2004 May; 54(5):343-8. PubMed ID: 15086839
[TBL] [Abstract][Full Text] [Related]
4. [Uterine leiomyoma with massive lymphoid infiltration: case report].
Zouari IB; Gouiaa N; Charfi S; Ellouze S; Chaari C; Kessentini M; Hssini A; Boudawara TS
Ann Pathol; 2011 Apr; 31(2):98-101. PubMed ID: 21601114
[TBL] [Abstract][Full Text] [Related]
5. Unusual morphologic features of uterine leiomyomas treated with gonadotropin-releasing hormone agonists: massive lymphoid infiltration and vasculitis.
McClean G; McCluggage WG
Int J Surg Pathol; 2003 Oct; 11(4):339-44. PubMed ID: 14615835
[TBL] [Abstract][Full Text] [Related]
6. Uterine leiomyomas with lymphoid infiltration simulating lymphoma. A report of seven cases.
Ferry JA; Harris NL; Scully RE
Int J Gynecol Pathol; 1989; 8(3):263-70. PubMed ID: 2670790
[TBL] [Abstract][Full Text] [Related]
7. Frequency, histological, and immunohistochemical properties of massive inflammatory lymphocytic infiltration of leiomyomas of the uterus: an entity causing diagnostic difficulties.
Botsis D; Koliopoulos C; Kondi-Pafitis A; Creatsas G
Int J Gynecol Pathol; 2005 Oct; 24(4):326-9. PubMed ID: 16175076
[TBL] [Abstract][Full Text] [Related]
8. Massive lymphocytic infiltration of uterine leiomyomas associated with GnRH agonist treatment.
Bardsley V; Cooper P; Peat DS
Histopathology; 1998 Jul; 33(1):80-2. PubMed ID: 9726054
[TBL] [Abstract][Full Text] [Related]
9. Uterine leiomyoma with massive lymphocytic infiltration simulating malignant lymphoma. A case report with immunohistochemical study showing that the infiltrating lymphocytes are cytotoxic T cells.
Chuang SS; Lin CN; Li CY; Wu CH
Pathol Res Pract; 2001; 197(2):135-8. PubMed ID: 11261818
[TBL] [Abstract][Full Text] [Related]
10. Uterine myoma with massive lymphocytic infiltration - case report.
Wasyluk T; Obrzut B; Gałązka K; Żmuda M; Obrzut M; Darmochwał-Kolarz D
Prz Menopauzalny; 2019 Jun; 18(2):123-125. PubMed ID: 31485209
[TBL] [Abstract][Full Text] [Related]
11. Effect of gonadotropin-releasing hormone agonists on monocyte chemotactic protein-1 production and macrophage infiltration in leiomyomatous uterus.
Sozen I; Senturk LM; Arici A
Fertil Steril; 2001 Oct; 76(4):792-6. PubMed ID: 11591415
[TBL] [Abstract][Full Text] [Related]
12. The histopathology of uterine leiomyomas following treatment with gonadotropin-releasing hormone analogues.
Colgan TJ; Pendergast S; LeBlanc M
Hum Pathol; 1993 Oct; 24(10):1073-7. PubMed ID: 8406417
[TBL] [Abstract][Full Text] [Related]
13. Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma.
Abulafia O; Kleinhaus K; Levi G; Lee YC; Sherer DM
Gynecol Obstet Invest; 2001; 52(2):108-13. PubMed ID: 11586038
[TBL] [Abstract][Full Text] [Related]
14. Uterine leiomyomas with T-cell infiltration associated with GnRH agonist goserelin.
Laforga JB; Aranda FI
Histopathology; 1999 May; 34(5):471-2. PubMed ID: 10231516
[No Abstract] [Full Text] [Related]
15. Morphological changes in uterine leiomyomas treated by GnRH agonist goserelin.
Crow J; Gardner RL; McSweeney G; Shaw RW
Int J Gynecol Pathol; 1995 Jul; 14(3):235-42. PubMed ID: 8600075
[TBL] [Abstract][Full Text] [Related]
16. Uterine leiomyoma with prominent lymphoid infiltrate.
Sağlam A; Güler G; Taşkin M; Ayhan A; Uner AH
Int J Gynecol Cancer; 2005; 15(1):167-70. PubMed ID: 15670313
[TBL] [Abstract][Full Text] [Related]
17. Ultrastructural comparison of uterine leiomyoma cells from the same myoma nodule before and after gonadotropin-releasing hormone agonist treatment.
Ito F; Kawamura N; Ichimura T; Tsujimura A; Ishiko O; Ogita S
Fertil Steril; 2001 Jan; 75(1):125-30. PubMed ID: 11163826
[TBL] [Abstract][Full Text] [Related]
18. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Malik M; Britten J; Cox J; Patel A; Catherino WH
Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
[TBL] [Abstract][Full Text] [Related]
19. Leiomyoma of the uterus with massive lymphoid infiltration simulating lymphoma. A case report.
Botsis D; Trakakis E; Kondis-Pafitis A; Kontoravdis A; Kassanos D; Chryssikopoulos A; Creatsas G
Eur J Gynaecol Oncol; 1999; 20(1):61-2. PubMed ID: 10422685
[No Abstract] [Full Text] [Related]
20. Down-regulation of proliferation and up-regulation of apoptosis by gonadotropin-releasing hormone agonist in cultured uterine leiomyoma cells.
Wang Y; Matsuo H; Kurachi O; Maruo T
Eur J Endocrinol; 2002 Mar; 146(3):447-56. PubMed ID: 11888853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
